EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Nationwide study on development and validation of a risk prediction model for CIN3+ and cervical cancer in Estonia

Anna Tisler, Andres Võrk, Martin Tammemägi, Sven Erik Ojavee, Mait Raag, Aleksandra Šavrova, Mari Nygård, Jan F Nygård, Mindaugas Stankunas, Anda Kivite-Urtane, Anneli Uusküla

Scientific Reports · 2024

DOI: 10.1038/s41598-024-75697-3 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Scientific Reports, 2024. Verfasst von Anna Tisler und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411, Tartu, Estonia. anna.tisler@ut.ee. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Economic Area, Eesti Teadusagentuur.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transitioning to an individualized risk-based approach can significantly enhance cervical cancer screening programs. We aimed to derive and internally validate a prediction model for assessing the risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) and cancer in women eligible for screening. This retrospective study utilized data from the Estonian electronic health records, including 517,884 women from the health insurance database and linked health registries. We employed Cox proportional hazard regression, incorporating reproductive and medical history variables (14 covariates), and utilized the least absolute shrinkage and selection operator (LASSO) for variable selection. A 10-fold cross-validation for internal validation of the model was used. The main outcomes were the performance of discrimination and calibration. Over the 8-year follow-up, we identified 1326 women with cervical cancer and 5929 with CIN3+, with absolute risks of 0.3% and 1.1%, respectively. The prediction model for CIN3 + and cervical cancer had good discriminative power and was well calibrated Harrell’s C of 0.74 (0.73–0.74) (calibration slope 1.00 (0.97–1.02) and 0.67 (0.66–0.69) (calibration slope 0.92 (0.84–1.00) respectively. A developed model based on nationwide electronic health data showed potential utility for risk stratification to supplement screening efforts. This work was supported through grants number PRG2218 from the Estonian Research Council, and EMP416 from the EEA (European Economic Area) and Norway Grants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsUterine Cervical DysplasiaHumansFemaleEstoniaMiddle AgedAdultRetrospective StudiesEarly Detection of CancerRisk AssessmentProportional Hazards ModelsAged

Stichwörter der Autor:innen

Cervical cancerHealth dataHigh-grade lesionsModelPredictionScreening

Autor:innen und Institutionen

  • Institute of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411, Tartu, Estonia. anna.tisler@ut.ee.
  • Johan Skytte Institute of Political Studies, University of Tartu, Tartu, Estonia.
  • Department of Health Sciences, Brock University, St Catharines, ON, Canada.
  • Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
  • Institute of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
  • Estonian Health Insurance Fund, Tartu, Estonia.

Förderung

  • European Economic Area
  • Eesti Teadusagentuur

Zitieren

APA

Tisler, A., Võrk, A., Tammemägi, M., Ojavee, S. E., Raag, M., Šavrova, A., Nygård, M., Nygård, J. F., Stankunas, M., Kivite-Urtane, A., & Uusküla, A. (2024). Nationwide study on development and validation of a risk prediction model for CIN3+ and cervical cancer in Estonia. Scientific Reports. https://doi.org/10.1038/s41598-024-75697-3

Vancouver

Tisler A, Võrk A, Tammemägi M, Ojavee SE, Raag M, Šavrova A, et al. Nationwide study on development and validation of a risk prediction model for CIN3+ and cervical cancer in Estonia. Scientific Reports. 2024. doi:10.1038/s41598-024-75697-3

BibTeX
@article{Tisler2024,
  author = {Tisler, Anna and Võrk, Andres and Tammemägi, Martin and Ojavee, Sven Erik and Raag, Mait and Šavrova, Aleksandra and Nygård, Mari and Nygård, Jan F and Stankunas, Mindaugas and Kivite-Urtane, Anda and Uusküla, Anneli},
  title = {Nationwide study on development and validation of a risk prediction model for CIN3+ and cervical cancer in Estonia},
  journal = {Scientific Reports},
  year = {2024},
  doi = {10.1038/s41598-024-75697-3}
}
Kostenlos starten →